Abstract
Executive Summary
- AIM, SCOPE AND ORGANIZATION OF REPORT
- CIENTIFICA NANOTECHNOLOGY MODEL
- Definitions of Nanotechnologies
- Major Assumptions
- BACKGROUND
Aim, Scope and Organization of Report
This report will give Pharma investors a comprehensive understanding on the
impact of nanotechnologies on the pharmaceutical market and companies, which
include companies that are producing nanomaterials/technologies to enable
better drug delivery compounds (drug delivery company) and companies that are
using nano-enabled formulations to enhance drug delivery (drug formulation
company).
This report will provide an in-depth discussion on recent developments of
nanoparticleenabled drug delivery systems (DDS) and future opportunities. It
is tailored for investors who plan to invest in the pharmaceutical industry
with an eye towards how nanoparticle drug delivery technology will impact the
economics of the pharmaceutical market.
The information includes business summaries, technology core competencies, how
nanoparticle adds value for investors in drug delivery companies,
comercialization strategies, intellectual property and available markets.
There are 58 case studies on nanoparticle DDS listed according to 3 categories:
- Delivery Method/Routes of administration
- Oral administration
- Transdermal delivery
- Injectable delivery
- Topical delivery
- Inhaled/nasal/pulmonary delivery
- Implantable delivery
- Therapeutics
- Cancer therapy
- Vaccines
- Antibody
- DNA-based therapy
- Technology
- Nanoparticulate encapsulation
- Dendrimer-based targeted therapeutics technology
- Liposomes nanotechnology
- Nanotube technologies
- Nanoparticles coating technology
- Silica-chitosan nanocomposite
- Nanosome technology